These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31612424)

  • 1. Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.
    Tost M; Monreal JA; Armario A; Barbero JD; Cobo J; García-Rizo C; Bioque M; Usall J; Huerta-Ramos E; Soria V; ; Labad J
    Clin Drug Investig; 2020 Jan; 40(1):1-14. PubMed ID: 31612424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
    Soria V; González-Rodríguez A; Huerta-Ramos E; Usall J; Cobo J; Bioque M; Barbero JD; García-Rizo C; Tost M; Monreal JA; ; Labad J
    Psychoneuroendocrinology; 2018 Jul; 93():8-19. PubMed ID: 29680774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis.
    Barbero JD; Gutiérrez-Zotes A; Montalvo I; Creus M; Cabezas Á; Solé M; Algora MJ; Garcia-Parés G; Vilella E; Labad J
    Schizophr Res; 2015 Aug; 166(1-3):37-42. PubMed ID: 25982813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric aspects of hypothyroidism and treatment reversibility.
    Davis JD; Tremont G
    Minerva Endocrinol; 2007 Mar; 32(1):49-65. PubMed ID: 17353866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid dysfunction in major psychiatric disorders in a hospital based sample.
    Radhakrishnan R; Calvin S; Singh JK; Thomas B; Srinivasan K
    Indian J Med Res; 2013 Dec; 138(6):888-93. PubMed ID: 24521631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
    Misra M; Papakostas GI; Klibanski A
    J Clin Psychiatry; 2004 Dec; 65(12):1607-18; quiz 1590, 1760-1. PubMed ID: 15641865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.
    Van Rheenen TE; Lewandowski KE; Lipschitz JM; Burdick KE
    CNS Spectr; 2019 Feb; 24(1):16-21. PubMed ID: 30244687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders: A narrative review.
    Bioque M; González-Rodríguez A; Garcia-Rizo C; Cobo J; Monreal JA; Usall J; Soria V; ; Labad J
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110130. PubMed ID: 33045322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel uses of thyroid hormones in patients with affective disorders.
    Prange AJ
    Thyroid; 1996 Oct; 6(5):537-43. PubMed ID: 8936685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.
    Montalvo I; Gutiérrez-Zotes A; Creus M; Monseny R; Ortega L; Franch J; Lawrie SM; Reynolds RM; Vilella E; Labad J
    PLoS One; 2014; 9(2):e89428. PubMed ID: 24586772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders.
    Pompili M; Verzura C; Trovini G; Buscajoni A; Falcone G; Naim S; Nardella A; Sorice S; Baldessarini RJ; Girardi P
    Expert Opin Drug Saf; 2018 Feb; 17(2):197-205. PubMed ID: 28902525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders.
    Labad J
    Psychoneuroendocrinology; 2019 Apr; 102():24-36. PubMed ID: 30503781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders.
    Ryan KA; Dawson EL; Kassel MT; Weldon AL; Marshall DF; Meyers KK; Gabriel LB; Vederman AC; Weisenbach SL; McInnis MG; Zubieta JK; Langenecker SA
    Brain; 2015 May; 138(Pt 5):1424-34. PubMed ID: 25818869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men.
    Prinz PN; Scanlan JM; Vitaliano PP; Moe KE; Borson S; Toivola B; Merriam GR; Larsen LH; Reed HL
    J Gerontol A Biol Sci Med Sci; 1999 Mar; 54(3):M111-6. PubMed ID: 10191837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of psychotic symptoms on cognitive functioning in child and adolescent psychiatric inpatients with severe mood disorders.
    McCarthy JB; Weiss SR; Segovich KT; Barbot B
    Psychiatry Res; 2016 Oct; 244():223-8. PubMed ID: 27497293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism.
    Roca RP; Blackman MR; Ackerley MB; Harman SM; Gregerman RI
    Endocr Res; 1990; 16(4):415-47. PubMed ID: 2129342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mood disorders, psychopharmacology and thyroid hormones].
    Danilo Q; Gloger S; Valdivieso S; Ivelic J; Fardella C
    Rev Med Chil; 2004 Nov; 132(11):1413-24. PubMed ID: 15693206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy.
    Baumgartner A; von Stuckrad M; Müller-Oerlinghausen B; Gräf KJ; Kürten I
    J Affect Disord; 1995 Jun; 34(3):211-8. PubMed ID: 7560549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.